Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Rivian Automotive, Inc. (RIVN) vs GeneDx Holdings Corp (WGS) Price & Performance

Rivian Automotive, Inc.Trade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Rivian Automotive, Inc. vs GeneDx Holdings Corp — how do they compare? Rivian Automotive, Inc. trades at $16.03 (market cap $23.17B), while GeneDx Holdings Corp trades at $86.53 (market cap $2.58B). The key difference: Rivian Automotive, Inc. is far larger — about 9× GeneDx Holdings Corp's market cap. Which is the better fit depends on your goals.

RIVNWGS
Market Cap
$23.17B$2.58B
Sector
Consumer CyclicalTechnology
52-Week High
$22.45$167.51
52-Week Low
$12.50$34.51
Enterprise Value
$23.22B$2.61B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rivian Automotive, Inc.

Rivian Automotive (RIVN) trades at $16.17, up 2.73% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $18.70. The company continues to report significant net losses but has shown improvement in revenue growth and gross profit margins, while recent news highlights strong demand for the R2 SUV and advancements in autonomy capabilities.

The outlook for RIVN hinges on successful R2 production scaling and path to profitability, with upside potential from current levels but high execution risk amid competitive EV market pressures and persistent cash burn requiring ongoing financing.

GeneDx Holdings Corp

WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.

Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Rivian Automotive, Inc.

Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.

Read more on RIVN

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS